• Home
  • Practice Focus
    • Facial Plastic/Reconstructive
    • Head and Neck
    • Laryngology
    • Otology/Neurotology
    • Pediatric
    • Rhinology
    • Sleep Medicine
    • How I Do It
    • TRIO Best Practices
  • Business of Medicine
    • Health Policy
    • Legal Matters
    • Practice Management
    • Tech Talk
    • AI
  • Literature Reviews
    • Facial Plastic/Reconstructive
    • Head and Neck
    • Laryngology
    • Otology/Neurotology
    • Pediatric
    • Rhinology
    • Sleep Medicine
  • Career
    • Medical Education
    • Professional Development
    • Resident Focus
  • ENT Perspectives
    • ENT Expressions
    • Everyday Ethics
    • From TRIO
    • The Great Debate
    • Letter From the Editor
    • Rx: Wellness
    • The Voice
    • Viewpoint
  • TRIO Resources
    • Triological Society
    • The Laryngoscope
    • Laryngoscope Investigative Otolaryngology
    • TRIO Combined Sections Meetings
    • COSM
    • Related Otolaryngology Events
  • Search

Is It Time to De-Escalate Radiation Therapy in Patients with HPV+ HNC?

by Karen Appold • November 10, 2019

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
Print-Friendly Version

Karen Appold is a freelance medical writer based in New Jersey.

You Might Also Like

  • Study: Surgery, Radiation Therapy Equally Effective in Treating OPSCC
  • Primary Radiation vs. Primary Surgical Therapy for Cervical Esophageal Cancer
  • Fanconi Anemia Patients with HNSCC Tolerate Surgery Better than Radiation, Chemotherapy
  • HPV-Positive Oropharnygeal Cancer Has Better Prognosis than Tobacco-Induced Cancer
Explore This Issue
November 2019

How Radiotherapy Works

Radiotherapy works by damaging the DNA in cells. It can potentially kill all cells, but there is increased killing in malignant cells due to the fact that their DNA repair mechanisms often don’t function normally. When cancer cells with a significant DNA injury start to divide, they fall apart and die. “Because cancer cells divide more rapidly than normal cells and aren’t able to repair DNA damage as well, they are more likely to die than normal cells close to the cancer,” said Dr. Ramey.

For head and neck cancers, photons are generated within a machine called a linear accelerator and modulated as they leave the machine with a technique called intensity modulated radiation therapy (IMRT). “As the photon interacts with the patient, its DNA damage is either ignited directly by interacting with the dividing cells or via indirect actions with water within the body,” said David Clump, MD, PhD, assistant professor in the department of radiation oncology, UPMC Hillman Cancer Center, Pittsburgh, Pa. “As the photon interacts with water within the body, the water molecule is split to create a free radical that subsequently damages the DNA of dividing cells.”

The process is optimized by using technology to deliver a quality-assured, reproducible dosing of radiation that aims to minimize toxicity to normal tissues while targeting a tumor and its expected drainage pattern. “Treatments are then delivered over a series of weeks using a specific dose of radiation per treatment as well as a specific number of treatments called fractions,” Dr. Clump said.

Radiotherapy works best on cells in the active replication phase, outside of the G0 (resting) stage of the cell cycle. “As a result, actively replicating cancer cells are the best targets of radiotherapy and tend to respond more quickly,” said Dr. Page. “Normal tissue will exhibit some signs of radiotherapy response sooner or later in a course of therapy, depending on its radiation sensitivity.”

In addition to damaging dividing cells, radiotherapy also works by stimulating an immune response against the tumor. “The interaction of radiation with the immune system is complicated, and radiation can both suppress and enhance anti-tumor immunity depending on how it is delivered and what other treatments the patient receives,” said Dr. Sikora—KA

Pages: 1 2 3 4 | Single Page

Filed Under: Features, Head and Neck, Practice Focus Tagged With: head and neck cancer, HPV, HPV-positive oropharyngeal cancer, radiation therapyIssue: November 2019

You Might Also Like:

  • Study: Surgery, Radiation Therapy Equally Effective in Treating OPSCC
  • Primary Radiation vs. Primary Surgical Therapy for Cervical Esophageal Cancer
  • Fanconi Anemia Patients with HNSCC Tolerate Surgery Better than Radiation, Chemotherapy
  • HPV-Positive Oropharnygeal Cancer Has Better Prognosis than Tobacco-Induced Cancer

The Triological SocietyENTtoday is a publication of The Triological Society.

Polls

Would you choose a concierge physician as your PCP?

View Results

Loading ... Loading ...
  • Polls Archive

Top Articles for Residents

  • Applications Open for Resident Members of ENTtoday Edit Board
  • How To Provide Helpful Feedback To Residents
  • Call for Resident Bowl Questions
  • New Standardized Otolaryngology Curriculum Launching July 1 Should Be Valuable Resource For Physicians Around The World
  • Do Training Programs Give Otolaryngology Residents the Necessary Tools to Do Productive Research?
  • Popular this Week
  • Most Popular
  • Most Recent
    • The Dramatic Rise in Tongue Tie and Lip Tie Treatment

    • Otolaryngologists Are Still Debating the Effectiveness of Tongue Tie Treatment

    • Rating Laryngopharyngeal Reflux Severity: How Do Two Common Instruments Compare?

    • Keeping Watch for Skin Cancers on the Head and Neck

    • Is Middle Ear Pressure Affected by Continuous Positive Airway Pressure Use?

    • The Dramatic Rise in Tongue Tie and Lip Tie Treatment

    • Rating Laryngopharyngeal Reflux Severity: How Do Two Common Instruments Compare?

    • Is Middle Ear Pressure Affected by Continuous Positive Airway Pressure Use?

    • Otolaryngologists Are Still Debating the Effectiveness of Tongue Tie Treatment

    • Complications for When Physicians Change a Maiden Name

    • Excitement Around Gene Therapy for Hearing Restoration
    • “Small” Acts of Kindness
    • How To: Endoscopic Total Maxillectomy Without Facial Skin Incision
    • Science Communities Must Speak Out When Policies Threaten Health and Safety
    • Observation Most Cost-Effective in Addressing AECRS in Absence of Bacterial Infection

Follow Us

  • Contact Us
  • About Us
  • Advertise
  • The Triological Society
  • The Laryngoscope
  • Laryngoscope Investigative Otolaryngology
  • Privacy Policy
  • Terms of Use
  • Cookies

Wiley

Copyright © 2025 by John Wiley & Sons, Inc. All rights reserved, including rights for text and data mining and training of artificial technologies or similar technologies. ISSN 1559-4939